Unlock instant, AI-driven research and patent intelligence for your innovation.

2' Modified oligonucleotides

a technology of oligonucleotides and modified oligonucleotides, which is applied in the field of modified oligonucleotides, can solve the problems of less than completely satisfactory, and achieve the effect of stable nucleas

Inactive Publication Date: 2005-06-28
IONIS PHARMA INC
View PDF21 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0023]wherein the oligomer is more stable to nuclease than the corresponding oligomer wherein all A are H or OH.
[0024]The oligomeric materials of formula (2) are useful as therapeutic or prophylacti

Problems solved by technology

These approaches have certain results with regard to stereoisomerism and its associated impact on hybridization to the target sequences that make them less than completely satisfactory.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 2' Modified oligonucleotides
  • 2' Modified oligonucleotides
  • 2' Modified oligonucleotides

Examples

Experimental program
Comparison scheme
Effect test

example 1

Preparation of Nucleotides and Oligomers (A=NHAc)

[0065]2′-N-acetaminouridine was protected at the 5′-position and made reactive at the 3′-position for formation of a phosphodiester linkage conjugating the residues in an oligomer as follows:

[0066]2′-N-Acylaminouridine. To 152 mg of 2′-N-acylamino-3′, 5′-O-diacyluridine (Verheyden, J. P. H, et al., Org Chem (1971) 36:250-254) (0.411 mmol) in 25 ml of MeOH was added a catalytic amount of KCN. After 15 h, 1.00 g of silica gel was added, and the reaction was concentrated. The powder was added to the top of a 20 mm column of silica gel that had been equilibrated in 5% H2O in CH3CN. The column was eluted with 5% H2O in CH3CN using standard flash chromatography conditions (Still, W. C., et al., J Org Chem (1978) 43:2923-2925). Isolation and concentration of the product afforded 59.5 mg (50.8% yield) of product.

[0067]2′-N-Acylamino-5′-O-(4,4′-dimethoxytrityl)-uridine. To 59.5 mg of 2′-N-acylaminouridine (0.208 mmol) in 2.5 ml of dry pyridine...

example 2

Preparation of Nucleotides and Oligomers

[0070]

[0071]2′-S-phenylcytidine was prepared from 2,2′-anhydro-(1-B-D-arabinofuranosyl) cytosine-HCl (a cyclic nucleoside) by suitable treatment with thiophenol. The —NH2 of cytosine and 5′-hydroxy were protected and the 3′—OH activated as follows:

[0072]2′-S-Phenylthiocytidine. To a solution of 500 mg (1.91 mmol) of 2,2′-anhydro-(1-B-D-arabinofuranosyl)-cytosine hydrochloride (purchased from Sigma) in 50 ml of dry DMF and 1.86 ml of dry TEA (13.3 mmol) was added 0.980 ml (9.54 mmol, 5.0 equiv) of thiphenol. The reaction was stirred for 5 h and then concentrated. The residue was concentrated from MeOH onto 2.00 g of silica gel. The powder was added to the top of a 30 mm column of silica gel that was equilibrated with CH2Cl2. The column was then eluted with one column volume of CH2Cl2, then one column volume of 6.25% MeOH in CH2Cl2, then one column volume of 12.5% MeOH in CH2Cl2 and then 25% MeOH in CH2Cl2. Concentration of the product fractions...

example 3

Preparation of Additional Nucleotides and Oligomers

A. (A=OCH2COOEt)

[0077]The 2′-derivatized nucleoside was prepared from N4-benzoyl-3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)-cytidine by reaction with ethyl iodoacetate and deprotection of the 2′ and 5′ hydroxyls. The 5′ position was protected and the 3′ position converted to a group reactive to link hydroxyl groups.

[0078]N4-Benzoyl-2′-O-(ethoxycaronylmethyl)-3′, 5′-O-(tetraisopropyldisiloxane-1,3-diyl)-cytidine. The preparation of this compound was an adaptation of a similar reaction used for the preparation of the 2′-OMe (Inoue, H., et al., Nucleic Acids Res (1987) 15:6131-6149). To 250 mg of N4-benzoyl-3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)-cytidine (Markiewicz, W. J., J Chem Res (1979) 181-196) (0.424 mmol; first concentrated from benzene) was added 1.00 ml (8.45 mmol, 19.9 equiv) of ethyl iodoacetate, followed by 294 mg of Ag2O (1.27 mmol, 2.99 equiv). The mixture was rapidly stirred and heated at 42° C. for 32 h. The mixt...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Currentaaaaaaaaaa
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Login to View More

Abstract

Oligomers which have substituents on the 2′ position are resistant to oligonucleases and furthermore can be derivatized to deliver reagents or drugs, to carry label, or to provide other properties.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application is a continuation of application Ser. No. 09 / 131,647, filed Aug. 10, 1998, now U.S. Pat. No. 6,476,205, which is a continuation of application Ser. No. 08 / 467,422, filed Jun. 6, 1995, now U.S. Pat. No. 5,792,847, which is a continuation of application Ser. No. 08 / 240,508, filed May 10, 1994, now U.S. Pat. No. 5,466,786, which is a continuation of application Ser. No. 07 / 425,857, filed Oct. 24, 1989, now abandoned. The disclosure of each of the foregoing is hereby incorporated by reference in its entirety.TECHNICAL FIELD[0002]The invention relates to modified oligo-nucleotides useful in technologies which rely on complementarity or specificity of oligomer sequences for drug delivery or for direct interference with nucleic acid activity. More specifically, the invention concerns oligomers derivatized at the 2′ position, which are stable to nuclease activity.BACKGROUND ART[0003]There has been considerable activity in recent ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07H19/16C07H21/00C07H19/10C07H19/20C07H19/00C07H19/06C07H19/04C12N15/11A61K31/70A61K48/00C12N15/09C12N15/113
CPCC07H19/04C07H19/06C07H19/10C07H19/16C07H19/20C07H21/00C12N15/113C12N2310/3535C12N2310/321C12N2310/322C12N2310/3517C12N2310/3527C12N2310/353
Inventor BUHR, CHRIS A.MATTEUCCI, MARK
Owner IONIS PHARMA INC